Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-08T11:42:03.151Z Has data issue: false hasContentIssue false
  • English
  • Français

Evidence of Delays in Transferring Patients With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococcus to Long-Term–Care Facilities

Published online by Cambridge University Press:  02 January 2015

Elizabeth A. Bryce ,
Shelley M. Tiffin ,
Judith L. Isaac-Renton  and
Charles J. Wright
Elizabeth A. Bryce*
Affiliation:
Division of Medical Microbiology, University of British Columbia, Vancouver, British Columbia, Canada
Shelley M. Tiffin
Affiliation:
Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, British Columbia, Canada
Judith L. Isaac-Renton
Affiliation:
Division of Medical Microbiology, University of British Columbia, Vancouver, British Columbia, Canada
Charles J. Wright
Affiliation:
Department of Pathology and Laboratory Medicine, the Clinical Epidemiology and Evaluation Centre, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada
*
Division of Medical Microbiology, LSP1110, Vancouver Hospital, 855 West 12th Ave, Vancouver, British Columbia, CanadaV5Z1M9
Get access Rights & Permissions [Opens in a new window]

Abstract

This retrospective case-control study examined whether there was a difference in length of time awaiting long-term-care lacement for patients identified as having methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus compared to controls. Thirty-nine patients with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus waited for placement an average of 61 days longer than controls (P<.0002). The average number of requests for placement was 2.5 compared to 1.7 for controls (P=.015).

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 4 , April 2000 , pp. 270 - 271
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.British Columbia Laboratory Centre for Disease Control. British Columbia Guidelines for control of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Vancouver, British Columbia, Canada: Ministry of Health and Ministry Responsible for Seniors; 1997.Google Scholar
2.Health Canada. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada. VRE Working Group, Canadian Hospital Epidemiology Committee and the Laboratory Centre for Disease Control, Health Protection Branch. Canada Commun Dis Rep 1997;23S8(suppl): 1–1-1-16. http://www.hc-sc.gc.ca/hpb/lcdc/publicathtml.Google Scholar
3.Boyce, JM, Jackson, MM, Pugliese, G, Batt, MD, Fleming, D, Garner, JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol 1994;15:105–115.Google Scholar
4.Smith, PW, Rusnak, PG. Infection prevention and control in the long-term care facility. SHEA long-term care committee and APIC guidelines committee. Infect Control Hosp Epidemiol 1997;18:831–849.CrossRefGoogle ScholarPubMed